Study details
Enrolling now
Capsule Microbiota Transplant Therapy for Hidradenitis Suppurativa
University of Minnesota
NCT IDNCT06058520ClinicalTrials.gov data as of Apr 2026
Phase
EARLY_PHASE1
Target enrollment
16
Study length
about 2.9 years
Ages
18+
Locations
1 site in MN
About this study
This trial is testing a treatment called fecal microbiota transplant (FMT) to see if it can change the gut microbiome in people with hidradenitis suppurativa (HS). The goal is to understand how changes in the gut microbiome might affect the skin condition.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Fecal Microbiota - lyophilized
- 2.Take Placebo drug
PhaseEARLY_Phase 1
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low12%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Secondary: Change in Hidradenitis Suppurativa quality of life (HiSQOL), Change in skin pain numerical rating scale (NRS)